IDEAS home Printed from https://ideas.repec.org/a/epw/ejmed0/v3y2021i3id40897.html

Usefulness of PRP Therapy in Androgenic Alopecia

Author

Listed:
  • Zahed Parvez

    (Shaheed Suhrawardy Medical College Hospital, Bangladesh)

  • Samina Akter

    (Dr. Zahed's Hair and Skinic, Bangladesh)

  • Afia Tahsin Shobnom

    (Dr. Zahed’s Hair & Skinic, Bangladesh)

Abstract

Alopecia means loss of hair. Primarily there are two types of alopecia. Non-cicatricial alopecia and Cicatricial alopecia. Androgenic alopecia is non cicatricial localized alopecia and displays relatively high rates of occurrence in both men and women. Injections of platelet-rich plasma (PRP) have shown to be a successful regenerative treatment for androgenic alopecia. It is a well-tolerated procedure and easy to perform. The objective clinical results are good. It is safe and non-allergenic. In our institution, more than 300 patients were given PRP and their terminal hair mass, hair texture, anagen/telogen hair ratio, keratinocyte proliferation, blood vessel density, and other factors were assessed. More than 85 percent of patients who underwent PRP treatment, had a very positive outcome.

Suggested Citation

  • Zahed Parvez & Samina Akter & Afia Tahsin Shobnom, 2021. "Usefulness of PRP Therapy in Androgenic Alopecia," European Journal of Medical and Health Sciences, European Open Science, vol. 3(3), pages 93-95, May.
    • Handle: RePEc:epw:ejmed0:v:3:y:2021:i:3:id:40897
    DOI: 10.24018/ejmed.2021.3.3.897
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/ejmed/article/view/40897
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/ejmed/article/download/40897/9241
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/ejmed.2021.3.3.897?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:3:y:2021:i:3:id:40897. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.